Cencora
S&P 500
$321.57
+0.19%
Delayed · cached 15 min
Peer comparison
| Company | Price↕ | Market Cap↕ | P/E↕ | P/B↕ | ROE %↕ | ROCE %↕ | Div yield %↕ | Valuation |
|---|---|---|---|---|---|---|---|---|
| McKesson Corporation | $ 881.51 | $102.78B | 23.64 | -24.12 | -112.31 | 29.15 | 0.37 | — |
| Cencora | $ 321.57 | $61.36B | 23.87 | 20.11 | 50.94 | 10.12 | 0.73 | Above FV |
| Cardinal Health | $ 234.57 | $54.56B | 32.49 | -18.96 | -59.45 | 19.51 | 0.87 | — |
| Henry Schein | $ 88.36 | $9.85B | 25.76 | 3.13 | 12.61 | 8.01 | 0.00 | Above FV |
Price, market cap, P/E, P/B and dividend yield reflect the live quote (delayed, cached 15 min); ROE/ROCE from reported financials. The highlighted row is the current company. Click a column header to sort. Educational data only.
How to read the peer comparison
This table places the company beside others in the same industry on a few common measures. Comparison adds context that a single company's numbers cannot give on their own.
- Valuation multiples like P/E and P/B are most meaningful within the same industry, because different industries naturally trade at different levels. Comparing a company only to its peers is more useful than to the whole market.
- Return measures (ROE, ROCE) show how efficiently each company turns capital into profit. A company well ahead of or behind its peers here is worth understanding.
- No single column decides anything. A beginner reads the row across — valuation, returns, and size together — and treats the highlighted current company as one data point among its peers.
- Use the sortable headers to rank peers on any measure, but remember that "cheaper" or "higher" on one metric is a starting question, not an answer.
Educational only — not a recommendation to buy, sell, or hold any security.